Who invested in HexemBio?
3 investors are on record as having backed HexemBio — Stem cell therapy to rejuvenate aging blood cells, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
hexemb.ioHexemBio investors
Mid-Atlantic Bio Angels (MABA)Invests in early-stage life science companies with disruptive, regulated products and…their site
Treeo VC Manco, LLCInvests in AI-native B2B startups led by Turkish/immigrant founders, offering…seedtheir site
1 more investors on record for HexemBio.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
No round dates are on record for HexemBio. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed HexemBio are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.